Philips technology aids first successful use of LC Bead LUMI technology

Philips has announced that the first liver cancer patient has been treated with LC Bead LUMI technology, in conjunction with Philips' live image guidance systems.

This new treatment approach was developed through a collaboration between Philips and BTG and involves the use of a radiopaque embolic bead, which can be visualised during interventional procedures to evaluate the completeness of tumour treatment.

LC Bead LUMI was created using radiopacity technology that enables real-time visualisation of the bead's location during embolisation. Thanks to Philips' live image guidance system, interventional radiologists have more control and can target treatment more accurately.

The first patient to be treated in this way was able to benefit from the use of dedicated Philips 2D X-ray and 3D CBCT image guidance, allowing doctors to target a hypervascular tumour with the aim of blocking blood flow to achieve tumour necrosis.

Ronald Tabaksblat, business leader for image-guided therapy systems at Philips, said: "Our collaboration with BTG to provide enhanced visibility and guidance during interventional embolisation procedures is another important milestone in this exciting journey to help deliver excellent treatment and enhanced patient care."